Broadcom
AVGO
Salesforce
CRM
Qualcomm
QCOM
4
Oracle
ORCL
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
ALGS Aligos Therapeutics
- 5.830
- +0.470+8.77%
Close Apr 24 16:00 ET
- 5.900
- +0.070+1.20%
Post 16:26 ET
35.65MMarket Cap-0.28P/E (TTM)
5.900High5.280Low142.63KVolume5.320Open5.360Pre Close804.59KTurnover3.26%Turnover RatioLossP/E (Static)6.11MShares46.80052wk High-1.23P/B25.50MFloat Cap3.76052wk Low--Dividend TTM4.37MShs Float937.748Historical High--Div YieldTTM11.57%Amplitude3.760Historical Low5.641Avg Price1Lot Size
Aligos Therapeutics Key Stats
EPS
According to the latest financial report of Aligos Therapeutics, the latest earnings per share (TTM) for the company is -13.08. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Aligos Therapeutics's free cash flow? The latest report shows it as -18.43M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Aligos Therapeutics shows that the company's current ratio is 2.86, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Aligos Therapeutics, the quick ratio is 2.62, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Aligos Therapeutics? The latest ROE figure is -777.83%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Aligos Therapeutics, the total asset return on investment (ROA) is -103.65%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Aligos Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Aligos Therapeutics, the net profit margin is -13.06K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀